Skip to content

Screening for Early Lung Cancer in Shanghai, China

Screening and Diagnosing for Early Lung Cancer in Shanghai Communities With Imaging Procedures

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02185495
Enrollment
3000
Registered
2014-07-09
Start date
2014-07-31
Completion date
2017-09-30
Last updated
2014-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

Imaging procedures including chest X-ray and low-dose computed tomography may be effective in lung cancer early detection. Yet it is unknown whether low-dose computed tomography combined with computer aided detection (CAD) is more effective than LDCT in screening of early lung cancer.

Detailed description

The randomized clinical trial is to investigate and compare the effectiveness of CAD-guided low-dose computed tomography and low-dose computed tomography in lung cancer screening for community individuals in Shanghai, China. Thus, an imaging protocol which can detect early lung cancer in asymptomatic high risk patients will be proposed.

Interventions

BEHAVIORALObserver nodule detection

Radiologists will detect the nodules.

DEVICEComputer-aided nodule detection

Computed-aided detection (CAD) software will be used to detect the nodules.

Sponsors

Shanghai Zhongshan Hospital
CollaboratorOTHER
Shanghai Pulmonary Hospital, Shanghai, China
CollaboratorOTHER
Fudan University
CollaboratorOTHER
Ruijin Hospital
CollaboratorOTHER
Shanghai Public Health Clinical Center
CollaboratorOTHER_GOV
Shanghai Changzheng Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* Age of 55 to 74 years; smoking history of at least 30 pack-years; and if former smoker, have quit within 15 years * Age 50 or older ,20 or more pack-year history of smoking, and one additional risk factor (occupational exposure, residential radon exposure, cancer history, family history of lung cancer, history of lung disease) * Age 35 and one additional risk factor * Ability to accept LDCT examination and sign informed consent form

Exclusion criteria

* Individuals with any symptoms suggestive of lung cancer (e.g., vigorous coughing, chest pain, weight loss, blood-stained sputum) * Individuals with acute pulmonary abnormalities or those in poor health conditions or those have metallic implants or devices in the chest or back will be excluded due to the potential impact on the results as well as difficulty of acquiring the images. * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
The sensitivities of low-dose computed tomography and low-dose computed tomography with computer aided detection in detecting early lung cancer24monthsA questionaire will be recorded for each subject, including demographics, smoking history and disease history, etc. If a pulmonary nodule was found, the location, shape, size, margin and density will be recorded. A subject with a suspected malignant nodule, which was detected either by a radiologist or computed-aiding detection software, will refer to a physician for further management. Finally, the sensitivities of radiologist or software detection will be calculated.

Secondary

MeasureTime frame
The false positive rates between low-dose computed tomography and low-dose computed tomography with computer aided detection will be compared24months
Nodule detection rate6 months

Countries

China

Contacts

Primary ContactShiyuan Liu, MD
cjr.liushiyuan@vip.163.com+86-13761304518

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026